GSA Capital Partners LLP Purchases Shares of 127,591 Viemed Healthcare, Inc. $VMD

GSA Capital Partners LLP acquired a new position in Viemed Healthcare, Inc. (NASDAQ:VMD) during the second quarter, HoldingsChannel reports. The institutional investor acquired 127,591 shares of the company’s stock, valued at approximately $1,455,000.

Other large investors have also added to or reduced their stakes in the company. AQR Capital Management LLC bought a new position in shares of Viemed Healthcare during the 1st quarter valued at approximately $90,000. Jane Street Group LLC purchased a new position in shares of Viemed Healthcare in the first quarter valued at $394,000. Geode Capital Management LLC increased its position in Viemed Healthcare by 2.0% in the second quarter. Geode Capital Management LLC now owns 798,515 shares of the company’s stock worth $5,519,000 after purchasing an additional 15,353 shares during the last quarter. JPMorgan Chase & Co. increased its position in Viemed Healthcare by 3.0% in the second quarter. JPMorgan Chase & Co. now owns 174,551 shares of the company’s stock worth $1,206,000 after purchasing an additional 5,099 shares during the last quarter. Finally, Rhumbline Advisers raised its stake in Viemed Healthcare by 9.0% during the second quarter. Rhumbline Advisers now owns 51,456 shares of the company’s stock valued at $356,000 after purchasing an additional 4,228 shares in the last quarter. Institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Price Performance

Shares of Viemed Healthcare stock opened at $9.20 on Monday. The stock has a market cap of $350.43 million, a price-to-earnings ratio of 25.56 and a beta of 1.10. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.02 and a current ratio of 1.13. The stock has a 50 day moving average price of $11.10 and a 200-day moving average price of $9.83. Viemed Healthcare, Inc. has a one year low of $6.05 and a one year high of $12.61.

Viemed Healthcare (NASDAQ:VMD) last released its earnings results on Monday, August 3rd. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.05). Viemed Healthcare had a net margin of 4.81% and a return on equity of 10.16%. The company had revenue of $78.10 million for the quarter, compared to the consensus estimate of $78.00 million. Equities analysts expect that Viemed Healthcare, Inc. will post 0.42 EPS for the current year.

Insider Buying and Selling at Viemed Healthcare

In other Viemed Healthcare news, insider William Frazier sold 10,000 shares of the business’s stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $11.72, for a total transaction of $117,200.00. Following the transaction, the insider owned 73,214 shares in the company, valued at $858,068.08. The trade was a 12.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Timothy Smokoff sold 20,000 shares of the stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total transaction of $230,000.00. Following the completion of the sale, the director directly owned 75,518 shares in the company, valued at approximately $868,457. This represents a 20.94% decrease in their position. The SEC filing for this sale provides additional information. 20.60% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

VMD has been the subject of several research reports. Weiss Ratings upgraded shares of Viemed Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, August 3rd. Wall Street Zen downgraded shares of Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday. Finally, Freedom Capital cut shares of Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 5th. One equities research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold”.

Viemed Healthcare Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.